Artificial intelligence‐based detection of lymph node metastases by PET/CT predicts prostate cancer‐specific survival
Clinical Physiology and Functional Imaging · 2021-01 · 41 (1) · 62-67
DOI: 10.1111/cpf.12666 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Physiology and Functional Imaging, online erschienen am 18.10.2020. Verfasst von Pablo Borrelli und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Physiology, Region Västra Götaland, Sahlgrenska University Hospital, Gothenburg, Sweden. Hauptthemen laut MEDLINE: Artificial Intelligence. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 15 Literaturangaben. Gefördert von: Sveriges Regering, EXINI Diagnostics AB.
Abstract (Originalsprache)
Introduction
Lymph node metastases are a key prognostic factor in prostate cancer (PCa), but detecting lymph node lesions from PET/CT images is a subjective process resulting in inter‐reader variability. Artificial intelligence (AI)‐based methods can provide an objective image analysis. We aimed at developing and validating an AI‐based tool for detection of lymph node lesions.
Methods
A group of 399 patients with biopsy‐proven PCa who had undergone 18 F‐choline PET/CT for staging prior to treatment were used to train ( n = 319) and test ( n = 80) the AI‐based tool. The tool consisted of convolutional neural networks using complete PET/CT scans as inputs. In the test set, the AI‐based lymph node detections were compared to those of two independent readers. The association with PCa‐specific survival was investigated.
Results
The AI‐based tool detected more lymph node lesions than Reader B (98 vs. 87/117; p = .045) using Reader A as reference. AI‐based tool and Reader A showed similar performance (90 vs. 87/111; p = .63) using Reader B as reference. The number of lymph node lesions detected by the AI‐based tool, PSA, and curative treatment was significantly associated with PCa‐specific survival.
Conclusion
This study shows the feasibility of using an AI‐based tool for automated and objective interpretation of PET/CT images that can provide assessments of lymph node lesions comparable with that of experienced readers and prognostic information in PCa patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Clinical Physiology, Region Västra Götaland, Sahlgrenska University Hospital, Gothenburg, Sweden.
- Department of Electrical Engineering, Chalmers University of Technology, Gothenburg, Sweden.
- Eigenvision AB, Malmö, Sweden.
- Department of Clinical Physiology and Nuclear Medicine, Lund University and Skåne University Hospital, Malmö, Sweden.
- Department of Urology, Odense University Hospital, Odense, Denmark.
- Department of Clinical Research, University of Southern Denmark, Odense, Denmark.
ORCID-Profile: Pablo Borrelli, Måns Larsson, Johannes Ulén, Olof Enqvist, Elin Trägårdh, Mads Hvid Poulsen, Mike Allan Mortensen, Henrik Kjölhede, Poul Flemming Høilund-Carlsen, Lars Edenbrandt
Förderung
- Sveriges Regering
- EXINI Diagnostics AB
Zitieren
APA
Borrelli, P., Larsson, M., Ulén, J., Enqvist, O., Trägårdh, E., Poulsen, M. H., Mortensen, M. A., Kjölhede, H., Høilund-Carlsen, P. F., & Edenbrandt, L. (2021). Artificial intelligence‐based detection of lymph node metastases by PET/CT predicts prostate cancer‐specific survival. Clinical Physiology and Functional Imaging, 41(1), 62-67. https://doi.org/10.1111/cpf.12666
Vancouver
Borrelli P, Larsson M, Ulén J, Enqvist O, Trägårdh E, Poulsen MH, et al. Artificial intelligence‐based detection of lymph node metastases by PET/CT predicts prostate cancer‐specific survival. Clinical Physiology and Functional Imaging. 2021;41(1):62-67. doi:10.1111/cpf.12666
BibTeX
@article{Borrelli2021,
author = {Borrelli, Pablo and Larsson, Måns and Ulén, Johannes and Enqvist, Olof and Trägårdh, Elin and Poulsen, Mads Hvid and Mortensen, Mike Allan and Kjölhede, Henrik and Høilund-Carlsen, Poul Flemming and Edenbrandt, Lars},
title = {Artificial intelligence‐based detection of lymph node metastases by PET/CT predicts prostate cancer‐specific survival},
journal = {Clinical Physiology and Functional Imaging},
year = {2021},
volume = {41},
number = {1},
pages = {62--67},
doi = {10.1111/cpf.12666}
}
EUVIMED